Hydrogen Sulfide Prevents Advanced Glycation End-Products Induced Activation of the Epithelial Sodium Channel

Advanced glycation end-products (AGEs) are complex and heterogeneous compounds implicated in diabetes. Sodium reabsorption through the epithelial sodium channel (ENaC) at the distal nephron plays an important role in diabetic hypertension. Here, we report that H2S antagonizes AGEs-induced ENaC activ...

Full description

Bibliographic Details
Main Authors: Qiushi Wang, Binlin Song, Shuai Jiang, Chen Liang, Xiao Chen, Jing Shi, Xinyuan Li, Yingying Sun, Mingming Wu, Dan Zhao, Zhi-Ren Zhang, He-Ping Ma
Format: Article
Language:English
Published: Hindawi Limited 2015-01-01
Series:Oxidative Medicine and Cellular Longevity
Online Access:http://dx.doi.org/10.1155/2015/976848
id doaj-77aa8757063946d18c886e792c863021
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Qiushi Wang
Binlin Song
Shuai Jiang
Chen Liang
Xiao Chen
Jing Shi
Xinyuan Li
Yingying Sun
Mingming Wu
Dan Zhao
Zhi-Ren Zhang
He-Ping Ma
spellingShingle Qiushi Wang
Binlin Song
Shuai Jiang
Chen Liang
Xiao Chen
Jing Shi
Xinyuan Li
Yingying Sun
Mingming Wu
Dan Zhao
Zhi-Ren Zhang
He-Ping Ma
Hydrogen Sulfide Prevents Advanced Glycation End-Products Induced Activation of the Epithelial Sodium Channel
Oxidative Medicine and Cellular Longevity
author_facet Qiushi Wang
Binlin Song
Shuai Jiang
Chen Liang
Xiao Chen
Jing Shi
Xinyuan Li
Yingying Sun
Mingming Wu
Dan Zhao
Zhi-Ren Zhang
He-Ping Ma
author_sort Qiushi Wang
title Hydrogen Sulfide Prevents Advanced Glycation End-Products Induced Activation of the Epithelial Sodium Channel
title_short Hydrogen Sulfide Prevents Advanced Glycation End-Products Induced Activation of the Epithelial Sodium Channel
title_full Hydrogen Sulfide Prevents Advanced Glycation End-Products Induced Activation of the Epithelial Sodium Channel
title_fullStr Hydrogen Sulfide Prevents Advanced Glycation End-Products Induced Activation of the Epithelial Sodium Channel
title_full_unstemmed Hydrogen Sulfide Prevents Advanced Glycation End-Products Induced Activation of the Epithelial Sodium Channel
title_sort hydrogen sulfide prevents advanced glycation end-products induced activation of the epithelial sodium channel
publisher Hindawi Limited
series Oxidative Medicine and Cellular Longevity
issn 1942-0900
1942-0994
publishDate 2015-01-01
description Advanced glycation end-products (AGEs) are complex and heterogeneous compounds implicated in diabetes. Sodium reabsorption through the epithelial sodium channel (ENaC) at the distal nephron plays an important role in diabetic hypertension. Here, we report that H2S antagonizes AGEs-induced ENaC activation in A6 cells. ENaC open probability (PO) in A6 cells was significantly increased by exogenous AGEs and that this AGEs-induced ENaC activity was abolished by NaHS (a donor of H2S) and TEMPOL. Incubating A6 cells with the catalase inhibitor 3-aminotriazole (3-AT) mimicked the effects of AGEs on ENaC activity, but did not induce any additive effect. We found that the expression levels of catalase were significantly reduced by AGEs and both AGEs and 3-AT facilitated ROS uptake in A6 cells, which were significantly inhibited by NaHS. The specific PTEN and PI3K inhibitors, BPV(pic)  and LY294002, influence ENaC activity in AGEs-pretreated A6 cells. Moreover, after removal of AGEs from AGEs-pretreated A6 cells for 72 hours, ENaC PO remained at a high level, suggesting that an AGEs-related “metabolic memory” may be involved in sodium homeostasis. Our data, for the first time, show that H2S prevents AGEs-induced ENaC activation by targeting the ROS/PI3K/PTEN pathway.
url http://dx.doi.org/10.1155/2015/976848
work_keys_str_mv AT qiushiwang hydrogensulfidepreventsadvancedglycationendproductsinducedactivationoftheepithelialsodiumchannel
AT binlinsong hydrogensulfidepreventsadvancedglycationendproductsinducedactivationoftheepithelialsodiumchannel
AT shuaijiang hydrogensulfidepreventsadvancedglycationendproductsinducedactivationoftheepithelialsodiumchannel
AT chenliang hydrogensulfidepreventsadvancedglycationendproductsinducedactivationoftheepithelialsodiumchannel
AT xiaochen hydrogensulfidepreventsadvancedglycationendproductsinducedactivationoftheepithelialsodiumchannel
AT jingshi hydrogensulfidepreventsadvancedglycationendproductsinducedactivationoftheepithelialsodiumchannel
AT xinyuanli hydrogensulfidepreventsadvancedglycationendproductsinducedactivationoftheepithelialsodiumchannel
AT yingyingsun hydrogensulfidepreventsadvancedglycationendproductsinducedactivationoftheepithelialsodiumchannel
AT mingmingwu hydrogensulfidepreventsadvancedglycationendproductsinducedactivationoftheepithelialsodiumchannel
AT danzhao hydrogensulfidepreventsadvancedglycationendproductsinducedactivationoftheepithelialsodiumchannel
AT zhirenzhang hydrogensulfidepreventsadvancedglycationendproductsinducedactivationoftheepithelialsodiumchannel
AT hepingma hydrogensulfidepreventsadvancedglycationendproductsinducedactivationoftheepithelialsodiumchannel
_version_ 1725794824623226880
spelling doaj-77aa8757063946d18c886e792c8630212020-11-24T22:15:21ZengHindawi LimitedOxidative Medicine and Cellular Longevity1942-09001942-09942015-01-01201510.1155/2015/976848976848Hydrogen Sulfide Prevents Advanced Glycation End-Products Induced Activation of the Epithelial Sodium ChannelQiushi Wang0Binlin Song1Shuai Jiang2Chen Liang3Xiao Chen4Jing Shi5Xinyuan Li6Yingying Sun7Mingming Wu8Dan Zhao9Zhi-Ren Zhang10He-Ping Ma11Departments of Clinical Pharmacy and Cardiology, Institute of Clinical Pharmacy, The Second Affiliated Hospital, Harbin Medical University, Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, Harbin 150086, ChinaDepartments of Clinical Pharmacy and Cardiology, Institute of Clinical Pharmacy, The Second Affiliated Hospital, Harbin Medical University, Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, Harbin 150086, ChinaDepartments of Clinical Pharmacy and Cardiology, Institute of Clinical Pharmacy, The Second Affiliated Hospital, Harbin Medical University, Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, Harbin 150086, ChinaDepartments of Clinical Pharmacy and Cardiology, Institute of Clinical Pharmacy, The Second Affiliated Hospital, Harbin Medical University, Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, Harbin 150086, ChinaDepartments of Clinical Pharmacy and Cardiology, Institute of Clinical Pharmacy, The Second Affiliated Hospital, Harbin Medical University, Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, Harbin 150086, ChinaDepartments of Clinical Pharmacy and Cardiology, Institute of Clinical Pharmacy, The Second Affiliated Hospital, Harbin Medical University, Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, Harbin 150086, ChinaDepartments of Clinical Pharmacy and Cardiology, Institute of Clinical Pharmacy, The Second Affiliated Hospital, Harbin Medical University, Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, Harbin 150086, ChinaDepartments of Clinical Pharmacy and Cardiology, Institute of Clinical Pharmacy, The Second Affiliated Hospital, Harbin Medical University, Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, Harbin 150086, ChinaDepartments of Clinical Pharmacy and Cardiology, Institute of Clinical Pharmacy, The Second Affiliated Hospital, Harbin Medical University, Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, Harbin 150086, ChinaDepartments of Clinical Pharmacy and Cardiology, Institute of Clinical Pharmacy, The Second Affiliated Hospital, Harbin Medical University, Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, Harbin 150086, ChinaDepartments of Clinical Pharmacy and Cardiology, Institute of Clinical Pharmacy, The Second Affiliated Hospital, Harbin Medical University, Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, Harbin 150086, ChinaDepartment of Physiology, Emory University School of Medicine, Atlanta, GA 30322, USAAdvanced glycation end-products (AGEs) are complex and heterogeneous compounds implicated in diabetes. Sodium reabsorption through the epithelial sodium channel (ENaC) at the distal nephron plays an important role in diabetic hypertension. Here, we report that H2S antagonizes AGEs-induced ENaC activation in A6 cells. ENaC open probability (PO) in A6 cells was significantly increased by exogenous AGEs and that this AGEs-induced ENaC activity was abolished by NaHS (a donor of H2S) and TEMPOL. Incubating A6 cells with the catalase inhibitor 3-aminotriazole (3-AT) mimicked the effects of AGEs on ENaC activity, but did not induce any additive effect. We found that the expression levels of catalase were significantly reduced by AGEs and both AGEs and 3-AT facilitated ROS uptake in A6 cells, which were significantly inhibited by NaHS. The specific PTEN and PI3K inhibitors, BPV(pic)  and LY294002, influence ENaC activity in AGEs-pretreated A6 cells. Moreover, after removal of AGEs from AGEs-pretreated A6 cells for 72 hours, ENaC PO remained at a high level, suggesting that an AGEs-related “metabolic memory” may be involved in sodium homeostasis. Our data, for the first time, show that H2S prevents AGEs-induced ENaC activation by targeting the ROS/PI3K/PTEN pathway.http://dx.doi.org/10.1155/2015/976848